HomeTARS • NASDAQ
add
Tarsus Pharmaceuticals Inc
Previous close
$43.50
Day range
$43.50 - $44.79
Year range
$20.08 - $57.28
Market cap
1.84B USD
Avg Volume
760.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 78.34M | 183.68% |
Operating expense | 85.00M | 64.79% |
Net income | -25.12M | 29.70% |
Net profit margin | -32.07 | 75.21% |
Earnings per share | -0.64 | 35.35% |
EBITDA | -25.82M | 30.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 407.92M | 36.64% |
Total assets | 500.75M | 43.37% |
Total liabilities | 158.29M | 113.71% |
Total equity | 342.46M | — |
Shares outstanding | 42.01M | — |
Price to book | 5.34 | — |
Return on assets | -14.97% | — |
Return on capital | -18.46% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -25.12M | 29.70% |
Cash from operations | -20.65M | 45.35% |
Cash from investing | -34.94M | 65.82% |
Cash from financing | 136.56M | 25.55% |
Net change in cash | 80.97M | 359.17% |
Free cash flow | -12.48M | 52.99% |
About
Founded
2016
Headquarters
Website
Employees
323
